The next-generation CaviWipes 2.0 builds on a decades-long reputation of being trusted by clinicians with strong efficacy claims paramount during times of public health crisis. Fully qualifies for the EPA's rigorous Emerging Viral Pathogen Claim.
    • Proven effective against SARS-CoV-2 on hard non-porous surfaces
    • EPA List N Compliant
    • Qualifies for the EPA’s Emerging Viral Pathogens claim for all virus types (enveloped, large and small non-enveloped viruses) to meet current and potentially future infection prevention needs
    • Enhanced Efficacy Claims - Effective against over 40 pathogens including Norovirus and Candida auris for added confidence in preventing healthcare associated infections.
    • Excellent Material Compatibilty - Compatible with most non-porous, hard surfaces commonly used in clinical settings
    • Easy to use label - Makes it quick and easy to find critical information on efficacy, compatibility, and more
    • 2-minute universal contact time for bacteria, viruses, and pathogenic fungi (Candida auris)

    CaviWipes™ 2.0

    Quantity Item Code Description Package Price ($)
    MET 14-1100 CaviWipes 2.0 ( 6"*6.75") 1 canister of 160 wipes $15.99
    MET 14-1100-12 CaviWipes 2.0 ( 6"*6.75") Case of 12 canisters($14.99 per canister) $183.06
    MET 14-1150 Caviwipes 2.0 Extra-large (9"*12") 1 canister of 65 wipes $19.95
    MET 14-1150-12 Caviwipes 2.0 Extra-large (9"*12") Case of 12 canisters($18.24 per canister) $218.00

    Related products